| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. | Director | Common Stock | 307,507 | $664,215 | $2.16 | 05 Dec 2024 | Direct |
| Allogene Therapeutics, Inc. | Director | Restricted Stock Unit | 95,400 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 21:03 |
| ALLO | Allogene Therapeutics, Inc. | 05 Dec 2024 | 1 | -$19,917 | 4 | Director | 09 Dec 2024, 16:05 |
| ALLO | Allogene Therapeutics, Inc. | 05 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 17:30 |
| ALLO | Allogene Therapeutics, Inc. | 30 May 2024 | 1 | -$26,181 | 4 | Director | 03 Jun 2024, 16:09 |
| ALLO | Allogene Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 17:01 |
| ALLO | Allogene Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:58 |
| ALLO | Allogene Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 17:45 |